| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |